Showing results (61-70 of 9,208) with videos related to

Sort By:
Pageof 921
Gut|July 16, 2008
Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammationF Caprioli, C Stolfi, R Caruso, et al.
Cancer|February 15, 1990
Effects of natural beta-interferon and recombinant alpha-2B-interferon on proliferation, glucocorticoid receptor content, and antigen expression in cultured HL-60 cellsG Sica, G Lama, R Tartaglione, et al.
Pathology, Research and Practice|November 1, 1989
Morphometry of in vitro systems. An image analysis of two human prostate cancer cell lines (PC3 and DU-145)G Carruba, C Pavone, M Pavone-Macaluso, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Effect of recombinant human interferon-alpha 2b on receptors for steroid hormones and epidermal growth factor in patients with endometrial cancerG Scambia, P B Panici, F Battaglia, et al.
Journal of Surgical Oncology. Supplement|January 1, 1993
Prognostic indicators in patients with cirrhosis and hepatocellular carcinoma undergoing surgical resectionM Bernardi, G L Grazi, A Colantoni, et al.
International Journal of Cancer|September 15, 1994
Effect of recombinant human interferon-alpha/2b on epidermal-growth-factor-, estrogen- and progesterone-receptor expression in primary cervical cancerG Scambia, P B Panici, G Ferrandina, et al.
Transplantation Proceedings|January 3, 2006
Anabolic steroid nandrolone augments hepatic regenerative response in ratsP Sileri, G Palmieri, P Gentileschi, et al.
Anticancer Research|November 1, 1992
Effect of natural beta-interferon on estrogen receptor mRNA of breast cancer cellsG Sica, C Angelucci, F Iacopino, et al.
Anticancer Research|January 1, 1996
Effects of interferon-beta on steroid receptors, prostaglandins and enzymatic activities in human endometrial cancerF De Cicco Nardone, F Rossiello, F Iacopino, et al.
Anticancer Research|August 6, 2000
Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot studyF Recchia, G Sica, S De Filippis, et al.
Pageof 921